All the news

People with cirrhosis of the liver had delayed and suboptimal responses to the Pfizer or Moderna SARS-CoV-2 vaccines compared to healthy adults, an Italian study has found. People with decompensated cirrhosis had significantly ...

Screening people admitted to hospital with COVID-19 for hepatitis C or hepatitis B does not lead to detection of a large number of undiagnosed infections and is likely to be of limited ...

Curing hepatitis C in people with mild fibrosis by the age of 50 reduces their risk of death to the same level as the rest of the population, Japanese researchers report in ...

The entry inhibitor bulevirtide (Hepcludex) suppressed hepatitis delta viral load and improved liver enzyme levels in a phase III clinical trial, according to late-breaking study results presented this week at the 2021 International Liver ...

Almost 7% of healthcare workers in Africa have hepatitis B and 5% have hepatitis C, according to a systematic review of published studies. Greater efforts to vaccinate against hepatitis B and improve ...

Screening for sexually transmitted infections in people co-infected with HIV and hepatitis C during or shortly after completing direct-acting antiviral treatment to cure hepatitis C may predict which patients are at higher risk ...

Pancreatic cancer occurred more often in people with hepatitis C or HIV in Canada’s British Columbia Hepatitis Testers Cohort, and colorectal cancer was more likely to occur in people diagnosed with hepatitis ...

People with HIV and hepatitis B co-infection remain at risk for developing hepatocellular carcinoma (HCC) despite antiviral treatment and should undergo regular monitoring for liver cancer, according to research presented ...